Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.00    -0.50 (-0.14%)
Bid:
351.00
Ask:
356.00
Spread: 5.00 (1.425%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

10 Dec 2013 11:23

RNS Number : 1596V
Caledonia Investments PLC
10 December 2013
Β 

ο»Ώ

NOTIFICATION OF TRANSACTION OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBIILTY AND CONNECTED PERSONS

Β 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

Β 

(i) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

Β 

(ii) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

Β 

(iii) An issuer making a notification in respect of options granted to a director / person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

Β 

(iv) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Β 

Β 

1

Name of the issuer:

Β 

Β 

CALEDONIA INVESTMENTS PLC

2

The notification relates to a transaction notified in accordance with:

Β 

DR 3.1.4R(1)(a).

Β 

3

Name of person discharging managerial responsibilities / director:

Β 

Β 

Β 

R D KENT

4

State whether the notification relates to a person connected with a person discharging managerial responsibilities /director named in 3 and identify the connected person:

Β 

N/A

Β 

5

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest:

Β 

BENEFICIAL HOLDING OF PERSON NAMED IN 3

Β 

6

Description of shares, debentures, derivatives or financial instruments relating to shares:

Β 

Β 

Β 

ORDINARY 5P SHARES

7

Name of registered shareholder and, if more than one, the number of shares held by each of them:

Β 

REYKER NOMINEES LIMITED A/C TFI

8

State the nature of the transaction:

Β 

Β 

Β 

PURCHASE OF SHARES

Β 

9

Number of shares acquired.

Β 

Β 

10,000

Β 

10

Percentage of issued class acquired (excluding treasury shares)

Β 

0.02%

Β 

11

Number of shares disposed:

Β 

NONE

12

Percentage of issued class disposed

Β 

NONE

Β 

Β 

13

Price per share or value of transaction

Β 

Β£19.13998 PER SHARE

Β 

Β 

Β 

Β 

Β 

14

Date and place of transaction

Β 

10 DECEMBER 2013, LONDON

15

Total holding and total percentage holding (excluding treasury shares)

Β 

Beneficial - 10,000 shares (0.02%)

Β 

16

Date issuer informed of transaction

Β 

Β 

Β 

17

Date of grant

Β 

Β 

N/A

18

Period during which or date on which it can be exercised

Β 

N/A

Β 

19

Total amount paid (if any) for grant of the option

Β 

N/A

Β 

20

Description of shares or debentures involved

Β 

N/A

21

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

Β 

N/A

22

Total number of shares or debentures over which options held following notification

Β 

N/A

Β 

Β 

23

Any additional information

Β 

NONE

24

Name of contact and telephone number for queries

Β 

K M BURWOOD

+44 20 7802 8080

Β 

Name and signature of duly authorised officer of issuer responsible for making notification

Β 

K M BURWOOD

DEPUTY COMPANY SECRETARY

Β 

Date of notification

10 DECEMBER 2013

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSFFEFFSFDSEEE
Date   Source Headline
27th May 20217:00 amRNSFinal Results
7th May 202111:39 amRNSNet Asset Value(s)
6th May 20218:13 amRNSHolding(s) in Company
9th Apr 20219:01 amRNSUnaudited net asset value and portfolio update
25th Mar 20215:45 pmRNSHolding(s) in Company
17th Mar 202110:03 amRNSDisposal
5th Mar 202112:27 pmRNSNet Asset Value(s)
16th Feb 20219:01 amRNSDirector Declaration
4th Feb 20219:11 amRNSNet Asset Value(s)
8th Jan 202110:39 amRNSNet Asset Value and Portfolio Update
7th Dec 202010:50 amRNSNet Asset Value(s)
27th Nov 20207:00 amRNSResult of Audit Tender
24th Nov 20207:00 amRNSHalf-year Report
6th Nov 202010:17 amRNSNet Asset Value(s)
7th Oct 202012:00 pmRNSNet Asset Value(s)
23rd Sep 20203:37 pmRNSDirector/PDMR Shareholding
22nd Sep 20209:13 amRNSHolding(s) in Company
21st Sep 20203:02 pmRNSDirector/PDMR Shareholding
4th Sep 20202:40 pmRNSNet Asset Value(s)
6th Aug 20204:08 pmRNSNet Asset Value(s)
5th Aug 20204:15 pmRNSDirector/PDMR Shareholding
5th Aug 20201:57 pmRNSDirector/PDMR Shareholding
29th Jul 20204:36 pmRNSResult of AGM
15th Jul 202010:52 amRNSPortfolio Update
7th Jul 202010:41 amRNSNet Asset Value(s)
1st Jul 202012:32 pmRNSBlock listing Interim Review
24th Jun 20204:37 pmRNSAnnual Financial Report
5th Jun 20209:05 amRNSNet Asset Value(s)
1st Jun 20205:20 pmRNSDirector/PDMR Shareholding
27th May 20207:00 amRNSFinal Results
19th May 20205:28 pmRNSDirector Declaration
7th May 20209:08 amRNSNet Asset Value(s)
30th Apr 20204:26 pmRNSDirector Declaration
28th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Apr 20206:06 pmRNSDisclosure of rights attached to equity shares
7th Apr 20207:00 amRNSNet Asset Value(s)
30th Mar 20203:37 pmRNSHolding(s) in Company
20th Mar 20204:41 pmRNSPrice Monitoring Extension
20th Mar 202010:10 amRNSHolding(s) in Company
5th Mar 202011:24 amRNSNet Asset Value(s)
6th Feb 202010:47 amRNSNet Asset Value(s)
7th Jan 20209:53 amRNSNet Asset Value(s)
2nd Jan 20208:00 amRNSBlock listing Interim Review
20th Dec 20199:43 amRNSCompany Secretary Change
17th Dec 20198:05 amRNSDirector/PDMR Shareholding
6th Dec 201910:23 amRNSNet Asset Value(s)
28th Nov 201910:05 amRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNSHalf-year Report
22nd Nov 20193:40 pmRNSDirector Declaration
7th Nov 20199:13 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.